Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
| Title: | Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial |
|---|---|
| Authors: | Sinclair, RodneyAff1; Mesinkovska, NatashaAff2; Mitra, DebanjaliAff3; Wajsbrot, DaliaAff3; Law, Ernest H.Aff3, IDs40257024008994_cor1; Wolk, RobertAff4; King, BrettAff5 |
| Source: | American Journal of Clinical Dermatology. 26(1):109-119 |
| Database: | Springer Nature Journals |